“RECENT UPDATE ON PYRIMIDINE DERIVATIVES AS POTENTIAL DPP-IV INHIBITORS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS”, Journal of Pharmaceutical Negative Results, pp. 5734–5743, Dec. 2022, Accessed: Jun. 11, 2026. [Online]. Available: https://www.pnrjournal.com/index.php/home/article/view/5581